Skip to contentR
Rocket Pharmaceuticals, Inc.
R
RCKTRocket Pharmaceuticals, Inc. Released Nov 9, 2016, before the open
10-Q filed Nov 9, 2016, 40 days after period end · 0001564590-16-028485
Q3 2016 · 10-Q
Revenue—
Net Income-$11.13M-$11.13MN/M vs Q3 2015N/M vs Q2 2016 EPS Diluted
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
-$0.41-$0.41N/M vs Q3 2015N/M vs Q2 2016 Operating Income-$10,723,000N/M Operating Cash Flowderived-$9,132,000N/M Free Cash Flowderived-$9,240,000N/M ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end